Erika-Nina Gurzeler-Tiihonen
Research Manager
GeneCellNano Flagship Coordinator
A.I. Virtanen Institute for Molecular Sciences, Faculty of Health Sciences
erika.gurzeler-tiihonen@uef.fi | +358 50 321 7972
Research groups
Projects
Publications
12/12 items-
Cardiovascular complications in diabetes : functional and gene expression profiling in diabetic mouse models with atherosclerosis
Gurzeler-Tiihonen, Erika. 2022. Publications of the University of Eastern Finland. Dissertations in Health Sciences -
Novel Designed Proteolytically Resistant VEGF-B186R127S Promotes Angiogenesis in Mouse Heart by Recruiting Endothelial Progenitor Cells
Mallick, Rahul; Gurzeler, Erika; Toivanen, Pyry I.; Nieminen, Tiina; Ylä-Herttuala, Seppo. 2022. Frontiers in bioengineering and biotechnology. 10: -
SUR1-E1506K mutation impairs glucose tolerance and promotes vulnerable atherosclerotic plaque phenotype in hypercholesterolemic mice
Gurzeler, Erika; Ruotsalainen, Anna-Kaisa; Laine, Anssi; Valkama, Teemu; Kettunen, Sanna; Laakso, Markku; Ylä-Herttuala, Seppo. 2021. PLoS ONE. 16: e025840 -
Doxycycline modulates VEGF-A expression: Failure of doxycycline-inducible lentivirus shRNA vector to knockdown VEGF-A expression in transgenic mice
Merentie, Mari; Rissanen, Riina; Lottonen-Raikaslehto, Line; Huusko, Jenni; Gurzeler, Erika; Turunen, Mikko P; Holappa, Lari; Mäkinen, Petri; Ylä-Herttuala, Seppo. 2018. PLoS ONE. 13: e0190981 -
Therapeutic effects of rosuvastatin in hypercholesterolemic prediabetic mice in the absence of low density lipoprotein receptor
Gurzeler, Erika; Aavik, Einari; Laine, Anssi; Valkama, Teemu; Niskanen, Henri; Huusko, Jenni; Kaikkonen, Minna U; Ylä-Herttuala, Seppo. 2018. Biochimica et biophysica acta: general subjects. 2019; 1863: 481-490 -
High Plasma Lipid Levels Reduce Efficacy of Adenovirus-Mediated Gene Therapy
Kivelä AM, Huusko J, Gurzeler E, Laine A, Dijkstra MH, Dragneva G, Andersen CB, Moestrup SK, Ylä-Herttuala S. 2017. Scientific reports. 7: 1-8 -
Left ventricular remodeling leads to heart failure in mice with cardiac-specific overexpression of VEGF-B167: echocardiography and magnetic resonance imaging study
Lottonen-Raikaslehto L, Rissanen R, Gurzeler E, Merentie M, Huusko J, Schneider JE, Liimatainen T, Ylä-Herttuala S. 2017. Physiological reports. 5: e13096 -
Vascular Endothelial Growth Factor-B Induces a Distinct Electrophysiological Phenotype in Mouse Heart
Naumenko N, Huusko J, Tuomainen T, Koivumäki JT, Merentie M, Gurzeler E, Alitalo K, Kivelä R, Ylä-Herttuala S, Tavi P. 2017. Frontiers in physiology. 8: 373 -
Angiopoietin-2 blocking antibodies reduce early atherosclerotic plaque development in mice
Theelen Thomas L, Lappalainen Jari P, Sluimer Judith C, Gurzeler Erika, Cleutjens Jack P, Gijbels Marion J, Biessen Erik AL, Daemen Mat JAP, Alitalo Kari, Ylä-Herttuala Seppo. 2015. Atherosclerosis. 241: 297-304 -
The effects of VEGF-A on atherosclerosis, lipoprotein profile, and lipoprotein lipase in hyperlipidaemic mouse models
Heinonen SE, Kivelä AM, Huusko J, Dijkstra MH, Gurzeler E, Mäkinen PI, Leppänen P, Olkkonen VM, Eriksson U, Jauhiainen M, Ylä-Herttuala S.. 2013. Cardiovascular research. 99: 716-23